A urinary catheter assembly comprises: a urinary catheter, a tubular case and a sleeve fixedly arranged over at least a part of a non-insertable section of the urinary catheter. The sleeve includes two oppositely arranged openings and a body extending between the opening. In a first position, a storage position, the tubular case is arranged to enclose the insertable section of the urinary catheter and is removably connected to the sleeve and/or to the non-insertable section of the urinary catheter. The body portion of the sleeve is provided with a first engagement member, and the tubular case is provided with a second engagement member, thereby enabling the tubular case, when removed from the non-insertable part of the urinary catheter, to be releasably connected to the sleeve in a second disposition, the second disposition being different from the first disposition. A method for producing a urinary catheter assembly is also disclosed.

An anesthetized catheter that includes the ability to administer substances and remove substances via the catheter orifice as well as pericatheter with the option of using wireless technology, while also having an indication system.

A ureteral stent assembly includes a ureteral stent, a bladder portion, and a stent pusher. The bladder portion is connected to the ureteral end of the ureteral stent with a tether. The stent pusher includes a bladder portion pusher. When the ureteral stent and the bladder portion are pushed into a predetermined position of the human body along a guidewire by the stent pusher, the guidewire passes through the ureteral stent, the bladder portion and the stent pusher, and the front end of the stent pusher is used to abut against the ureteral end of the ureteral stent. The bladder portion is sleeved on the front section of the stent pusher, and the bladder portion pusher is used to abut against the bladder portion.

Disclosed herein are systems, devices, and methods for the removal of objects from the body. The device may be a urethral catheter configured to aspirate kidney stones from the urinary tract through one or more aspiration ports at the distal face or along a lateral side of the catheter. The catheter may include one or more irrigation ports at the distal face or along the lateral side of the catheter for dislodging kidney stones. The device may be steerable. The spatial arrangement of the one or more irrigation ports with respect to the one or more aspiration ports may vary. The device may include an irrigation tube and/or a shield member configured to spatially confine the kidney stones adjacent the catheter. Various temporal patterns of aspiration and irrigation are disclosed for optimizing removal of kidney stones.

In one example, a system includes an elongated body defining a lumen where the elongated body includes a proximal portion and a distal portion. An anchoring member may be positioned on the proximal portion of the elongated body. The system further includes a sensor located on the elongated body where the sensor may be configured to sense at least one flow parameter of a fluid within the lumen. In some examples, the system includes processing circuitry configured to determine at least one of a density parameter or a temperature parameter of the fluid in the lumen based on the sensed at least one flow parameter of the fluid.

The present invention discloses the device for a urinary catheter employing electromagnetic radiation and/or vibration transducer. The device comprises a clip-on (4) including a source of electromagnetic radiation (5) and/or a vibration transducer and a coupler (3) that allows electromagnetic radiation access from clip-on to the inside of the coupler. The combination of electromagnetic radiation and photo catalyst material may increase effectiveness for antimicrobial activity. The device aims at preventing the catheter-associated urinary tract infection caused by both intraluminal and extraluminal routes.

Systems and methods for reducing pathogens near an implant are discussed. In some cases, the methods include reducing contaminants in a portion of a patient that has an implant and that is disposed interior to a closed surface of skin of the patient. The method can further include placing a conduit in the closed surface of skin and flowing an antimicrobial fluid into that portion of the patient to contact the antimicrobial fluid with a surface of the implant and tissue adjacent to the implant. In some cases, the antimicrobial fluid is then removed from the portion of the patient having the implant. As part of this method, biofilm near the implant can be mechanically, ultrasonically, electrically, chemically, enzymatically, or otherwise disrupted. Other implementations are described.

A urinary catheter assembly includes a urinary catheter sealed inside of a closed package. The urinary catheter has a first closure sealing a proximal opening and including a first extension portion that is coupled to the closed package, and a second closure sealing a distal opening and including a second extension portion coupled to the closed package.

A disposable device for treating a condition of a ureter or kidney having a cylindrical body about 1-2 mm in diameter by about 5 to 10 mm in length and having a top and bottom end. The body is made of absorbent material that expands upon contact with pharmaceutical agent and bodily fluids and includes a string connected to the bottom end of the body for removing the device. The device can be used to treat a condition of the ureter or kidney by inserting into the ureter or kidney, delivering a pharmaceutical agent, and removing the device after it has been impregnated with fluid. The device can be included in a kit with an insertion device and/or appropriate pharmaceutical agents.

A balloon catheter for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen; the ballon catheter comprising: An elongated balloon; a coating layer overlying an exterior surface of the balloon wherein the coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent; and a length-control mechanism (600) which stretches and elongates the balloon during deflation, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.